Sofosbuvir impurity G

CAS No. 1337482-15-1

Sofosbuvir impurity G( —— )

Catalog No. M26457 CAS No. 1337482-15-1

Sofosbuvir impurity G is both a diastereomer of Sofosbuvir and an impurity of Sofosbuvir which is an inhibitor of HCV RNA replication.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 3202 In Stock
5MG 2546 In Stock
10MG 3449 In Stock
25MG 5121 In Stock
50MG 6780 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sofosbuvir impurity G
  • Note
    Research use only, not for human use.
  • Brief Description
    Sofosbuvir impurity G is both a diastereomer of Sofosbuvir and an impurity of Sofosbuvir which is an inhibitor of HCV RNA replication.
  • Description
    Sofosbuvir impurity G is both a diastereomer of Sofosbuvir and an impurity of Sofosbuvir which is an inhibitor of HCV RNA replication.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    PARP1| PARP2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1337482-15-1
  • Formula Weight
    529.458
  • Molecular Formula
    C22H29FN3O9P
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (188.88 mM)
  • SMILES
    CC(C)OC(=O)[C@H](C)N[P@](=O)(O[C@@H]1[C@@H](CO)O[C@@H](n2ccc(=O)[nH]c2=O)[C@]1(C)F)Oc1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sch?fer P, Palacin T, Sidera M, Fletcher SP. Asymmetric Suzuki-Miyaura coupling of heterocycles via Rhodium-catalysed allylic arylation of racemates. Nat Commun. 2017 Jun 13;8:15762.
molnova catalog
related products
  • Filibuvir

    Filibuvir (PF-00868554;PF-868554) is a nonnucleoside, potent and selective, orally available HCV NS5B inhibitor with IC50 of 19 nM, EC50 of 75 nM.

  • LJH685

    LJH685 is an effective pan-RSK inhibitor for RSK1/2/3 (IC50: 6/5/4 nM).

  • Daclatasvir

    A potent HCV NS5A inhibitor with EC50 of <50 pM against genotype 1 replicons.